Cargando…

The impact of COVID-19 on community antibiotic use in Canada: an ecological study

OBJECTIVES: The COVID-19 pandemic has had an effect on the incidence of infectious diseases and medical care. This study aimed to describe the impact of the COVID-19 pandemic on community-level antibiotic use. METHODS: Using national antibiotic dispensing data from IQVIA's CompuScript database,...

Descripción completa

Detalles Bibliográficos
Autores principales: Knight, Braden D., Shurgold, Jayson, Smith, Glenys, MacFadden, Derek R., Schwartz, Kevin L., Daneman, Nick, Gravel Tropper, Denise, Brooks, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556063/
https://www.ncbi.nlm.nih.gov/pubmed/34757115
http://dx.doi.org/10.1016/j.cmi.2021.10.013
_version_ 1784592105799155712
author Knight, Braden D.
Shurgold, Jayson
Smith, Glenys
MacFadden, Derek R.
Schwartz, Kevin L.
Daneman, Nick
Gravel Tropper, Denise
Brooks, James
author_facet Knight, Braden D.
Shurgold, Jayson
Smith, Glenys
MacFadden, Derek R.
Schwartz, Kevin L.
Daneman, Nick
Gravel Tropper, Denise
Brooks, James
author_sort Knight, Braden D.
collection PubMed
description OBJECTIVES: The COVID-19 pandemic has had an effect on the incidence of infectious diseases and medical care. This study aimed to describe the impact of the COVID-19 pandemic on community-level antibiotic use. METHODS: Using national antibiotic dispensing data from IQVIA's CompuScript database, this ecological study investigated antibiotic dispensing through community retail pharmacies in Canada from November 2014 to October 2020. Analyses were stratified by age, sex, prescription origin and approximate indication. RESULTS: Adjusting for seasonality, the national rate of antibiotic dispensing in Canada decreased by 26.5% (50.4 to 37.0 average prescriptions per 1000 inhabitants) during the first 8 months of the Canadian COVID-19 period (March to October 2020), compared with the pre-COVID-19 period. Prescribing rates in children ≤18 years decreased from 43.7 to 12.2 prescriptions per 1000 inhabitants in males (–72%) and from 46.8 to 14.9 prescriptions per 1000 inhabitants in females (–68%) in April 2020. Rates in adults ≥65 decreased from 74.9 to 48.8 prescriptions per 1000 inhabitants in males (–35%) and from 91.7 to 61.3 prescriptions per 1000 inhabitants in females (–33%) in May 2020. Antibiotic prescriptions from family physicians experienced a greater decrease than from surgeons and infectious disease physicians. Prescribing rates for antibiotics for respiratory indications decreased by 56% in May 2020 (29.2 to 12.8 prescriptions per 1000 inhabitants), compared with prescribing rates for urinary tract infections (9.4 to 7.8 prescriptions per 1000 inhabitants; –17%) and skin and soft tissue infections (6.4 to 5.2 prescriptions per 1000 inhabitants; –19%). DISCUSSION: The first 8 months of the COVID-19 pandemic reduced community antibiotic dispensing by 26.5% in Canada, compared with the marginal decrease of 3% in antibiotic consumption between 2015 and 2019. Further research is needed to understand the implications and long-term effects of the observed reductions on antibiotic use on antibiotic resistance in Canada.
format Online
Article
Text
id pubmed-8556063
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-85560632021-11-01 The impact of COVID-19 on community antibiotic use in Canada: an ecological study Knight, Braden D. Shurgold, Jayson Smith, Glenys MacFadden, Derek R. Schwartz, Kevin L. Daneman, Nick Gravel Tropper, Denise Brooks, James Clin Microbiol Infect Original Article OBJECTIVES: The COVID-19 pandemic has had an effect on the incidence of infectious diseases and medical care. This study aimed to describe the impact of the COVID-19 pandemic on community-level antibiotic use. METHODS: Using national antibiotic dispensing data from IQVIA's CompuScript database, this ecological study investigated antibiotic dispensing through community retail pharmacies in Canada from November 2014 to October 2020. Analyses were stratified by age, sex, prescription origin and approximate indication. RESULTS: Adjusting for seasonality, the national rate of antibiotic dispensing in Canada decreased by 26.5% (50.4 to 37.0 average prescriptions per 1000 inhabitants) during the first 8 months of the Canadian COVID-19 period (March to October 2020), compared with the pre-COVID-19 period. Prescribing rates in children ≤18 years decreased from 43.7 to 12.2 prescriptions per 1000 inhabitants in males (–72%) and from 46.8 to 14.9 prescriptions per 1000 inhabitants in females (–68%) in April 2020. Rates in adults ≥65 decreased from 74.9 to 48.8 prescriptions per 1000 inhabitants in males (–35%) and from 91.7 to 61.3 prescriptions per 1000 inhabitants in females (–33%) in May 2020. Antibiotic prescriptions from family physicians experienced a greater decrease than from surgeons and infectious disease physicians. Prescribing rates for antibiotics for respiratory indications decreased by 56% in May 2020 (29.2 to 12.8 prescriptions per 1000 inhabitants), compared with prescribing rates for urinary tract infections (9.4 to 7.8 prescriptions per 1000 inhabitants; –17%) and skin and soft tissue infections (6.4 to 5.2 prescriptions per 1000 inhabitants; –19%). DISCUSSION: The first 8 months of the COVID-19 pandemic reduced community antibiotic dispensing by 26.5% in Canada, compared with the marginal decrease of 3% in antibiotic consumption between 2015 and 2019. Further research is needed to understand the implications and long-term effects of the observed reductions on antibiotic use on antibiotic resistance in Canada. The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2022-03 2021-10-30 /pmc/articles/PMC8556063/ /pubmed/34757115 http://dx.doi.org/10.1016/j.cmi.2021.10.013 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Knight, Braden D.
Shurgold, Jayson
Smith, Glenys
MacFadden, Derek R.
Schwartz, Kevin L.
Daneman, Nick
Gravel Tropper, Denise
Brooks, James
The impact of COVID-19 on community antibiotic use in Canada: an ecological study
title The impact of COVID-19 on community antibiotic use in Canada: an ecological study
title_full The impact of COVID-19 on community antibiotic use in Canada: an ecological study
title_fullStr The impact of COVID-19 on community antibiotic use in Canada: an ecological study
title_full_unstemmed The impact of COVID-19 on community antibiotic use in Canada: an ecological study
title_short The impact of COVID-19 on community antibiotic use in Canada: an ecological study
title_sort impact of covid-19 on community antibiotic use in canada: an ecological study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556063/
https://www.ncbi.nlm.nih.gov/pubmed/34757115
http://dx.doi.org/10.1016/j.cmi.2021.10.013
work_keys_str_mv AT knightbradend theimpactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT shurgoldjayson theimpactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT smithglenys theimpactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT macfaddenderekr theimpactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT schwartzkevinl theimpactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT danemannick theimpactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT graveltropperdenise theimpactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT brooksjames theimpactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT knightbradend impactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT shurgoldjayson impactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT smithglenys impactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT macfaddenderekr impactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT schwartzkevinl impactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT danemannick impactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT graveltropperdenise impactofcovid19oncommunityantibioticuseincanadaanecologicalstudy
AT brooksjames impactofcovid19oncommunityantibioticuseincanadaanecologicalstudy